The Path EX device is being developed to diagnose and treat sepsis through the removal of pathogens and endotoxins from circulating blood. Pre-clinical studies have demonstrated that the device can reduce the concentration of pathogens by approximately 95% in a single pass of contaminated blood. In October 2020, Path EX received $100,000 for winning the Diamond Prize from MassChallenge. To-date, the company has raised approximately $740,000.

EKO raises $65M in Series C round

EKO develops and commercializes digital stethoscopes and stethoscope accessories. The company’s flagship device is the FDA cleared DUO ECG & Stethoscope, which combines an ECG and stethoscope into a single handheld device. In addition to their own stethoscopes, the company has partnered with 3M to integrate their CORE technology with 3M’s Littmann digital stethoscope. Following the completion of this recent fundraising round, the company has raised approximately $95.5M.

Razor Medical Instruments – optimizing patient safety and surgical outcomes in orthopedic surgery

The company is developing single-use instruments for use in large-joint replacement surgeries. Razor Medical Instruments recently completed a Seed round in which the company raised $700,000. Key strategics in the orthopedic surgery market include DePuy Synthes, Smith & Nephew, and Zimmer-Biomet.

StartBox is preventing wrong site surgery using its data-driven approach

The StartBox Patient Safety Solution pairs a surgical safety kit with a cloud-based system to prevent wrong site surgery and capture near misses in real-time. The system allows healthcare providers to flag errors in real-time to prevent wrong site surgery and costly medicolegal risks. To-date, the company has raised approximately $8.8M. Cardinal Health, Johnson & Johnson, and Stryker are some of the major competitors in this market.